Cargando…
Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region
[Image: see text] Influenza A viruses pose a serious pandemic risk, while generation of efficient vaccines against seasonal variants remains challenging. There is thus a pressing need for new treatment options. We report here a set of macrocyclic peptides that inhibit influenza A virus infection at...
Autores principales: | Pascha, Mirte N., Thijssen, Vito, Egido, Julia E., Linthorst, Mirte W., van Lanen, Jipke H., van Dongen, David A. A., Hopstaken, Antonius J. P., van Kuppeveld, Frank J. M., Snijder, Joost, de Haan, Cornelis A. M., Jongkees, Seino A. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486808/ https://www.ncbi.nlm.nih.gov/pubmed/35926224 http://dx.doi.org/10.1021/acschembio.2c00040 |
Ejemplares similares
-
Selective thiazoline peptide cyclisation compatible with mRNA display and efficient synthesis
por: Liu, Minglong, et al.
Publicado: (2023) -
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Creytens, Sarah, et al.
Publicado: (2021) -
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT)
por: van Haren, Matthijs J., et al.
Publicado: (2021) -
Inhibition of Influenza H7 Hemagglutinin-Mediated Entry
por: Antanasijevic, Aleksandar, et al.
Publicado: (2013) -
Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant
por: de Vries, Erik, et al.
Publicado: (2015)